
This medication is compounded by a licensed 503A pharmacy in accordance with Section 503A of the Federal Food, Drug & Cosmetic Act, and may only be dispensed pursuant to a valid, patient-specific prescription issued by a licensed healthcare practitioner following an individualized medical evaluation. The FDA does not review or approve compounded medications, including compounded tirzepatide, for safety, effectiveness, or quality. Compounded tirzepatide has not been FDA-approved for weight loss or any other indication, though peer-reviewed and third-party research suggests potential clinical benefits. Individual results will vary. This compounded formulation is not affiliated with, endorsed by, reviewed by, or intended to replace any FDA-approved product manufactured by Eli Lilly and Company. EOS Health and its pharmacy partners have no affiliation with Eli Lilly and Company.
Compounded Tirzepatide + B12 + Glycine combines a once-weekly GLP-1 and GIP dual-agonist with both vitamin B12 and the amino acid glycine in a single injection. The tirzepatide acts on two hormone pathways involved in appetite and digestion; vitamin B12 is included for its role in energy metabolism, and glycine for its role in muscle-protein pathways. Shipped from Strive Pharmacy, a licensed 503A compounding pharmacy.
Two-hormone mechanism: Tirzepatide acts on both the GLP-1 and GIP receptors, the pathways involved in satiety signaling and gastric emptying.
Vitamin B12 included: B12 has a role in red blood cell production and energy metabolism, and is built into the formulation rather than taken separately.
Glycine included: An amino acid involved in muscle-protein pathways, built into the formulation for patients also focused on body composition alongside adequate protein intake and strength training.
Appetite and fullness: Acts on the signals that regulate hunger and how long you feel full after eating.
Once-weekly dosing: One subcutaneous injection per week, with dosing set and adjusted by your clinician.
Blood sugar regulation: Influences insulin and glucagon signaling as part of how the medication acts on metabolism.